nifedipine has been researched along with Cor Pulmonale in 30 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To observe the long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale." | 9.08 | [The long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale]. ( Cheng, X; Li, Q; Yao, Z, 1997) |
| "A two-year-old child dying of pulmonary hypertension and cor pulmonale secondary to bronchopulmonary dysplasia, was demonstrated to have reactive pulmonary hypertension in response to 100% oxygen and isoproterenol infusion." | 9.06 | Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia. ( Bingham, WT; Duncan, WJ; Kasian, GF; Mersal, A; Ninan, A; Sankaran, K; Tyrrell, MJ, 1988) |
| "The effects of a single dose of nifedipine (20 mg sublingual) on the haemodynamics and parameters of tissue oxygenation were assessed by right heart catheterisation and oximetry of mixed arterial and venous blood in 24 patients with pulmonary hypertension secondary to severe chronic obstructive airways disease." | 7.67 | [Nifedipine in the treatment of chronic cor pulmonale]. ( Arnaud, A; Philip-Joet, F; Saadjian, A; Torresani, J; Tran N'guyen, A, 1986) |
| "The present study was undertaken to evaluate the short-term effects of nitroglycerin, nifedipine, and supplemental oxygen on hemodynamics and gas exchange in 11 patients in stable condition with chronic obstructive pulmonary disease and cor pulmonale." | 7.67 | Pulmonary vasodilator therapy for chronic obstructive pulmonary disease and cor pulmonale. Treatment with nifedipine, nitroglycerin, and oxygen. ( Belli, A; Giudice, JC; Morley, TF; Zappasodi, SJ, 1987) |
| "After 20 mg sublingual nifedipine in 12 men with clinical stable chronic cor pulmonale the mean arterial pressure and systemic vascular resistance fell, cardiac index rose, and mean pulmonary arterial (Ppa) and wedge (Ppaw) pressures, right atrial pressure, and PaO2 remained unchanged." | 7.67 | Nifedipine in chronic cor pulmonale: acute and relatively long-term effects. ( Ashutosh, K; Dunsky, M; Hill, N; Mookherjee, S; Smulyan, H; Vardan, S; Warner, R, 1988) |
| "The effects of a single dose of nifedipine (20 mg sublingually) on hemodynamics and tissue oxygenation were evaluated in 24 patients suffering from pulmonary hypertension secondary to severe chronic obstructive lung disease." | 7.67 | Hemodynamic and oxygen delivery responses to nifedipine in pulmonary hypertension secondary to chronic obstructive lung disease. ( Arnaud, A; Philip-Joet, F; Saadjian, A, 1987) |
| "In the present study the response of the pulmonary circulation to a vasodilator agent (nifedipine) and to low-flow oxygen (FiO2 35%) has been studied both at rest and during exercise (steady state, 25 W) in nine patients with severe scoliosis (spinal curve + 100 degrees, FVC 38%)." | 7.67 | Effects of nifedipine and oxygen on pulmonary haemodynamics in severe scoliosis. ( Corbascio, M; Cornia, BM; Papiris, S; Sturani, C, 1987) |
| "Nifedipine has recently been reported to reduce pulmonary artery pressure and pulmonary vascular resistance during rest and exercise in adult patients with hypoxic pulmonary hypertension from chronic obstructive pulmonary disease." | 5.27 | Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale. ( Fitzpatrick, S; Kennedy, TP; Michael, JR; Rosenstein, BJ, 1984) |
| " The benefit of long-term administration of nifedipine is difficult to predict on the basis of short-term effects." | 5.27 | Oral nifedipine in chronic cor pulmonale secondary to severe chronic obstructive pulmonary disease (COPD). ( Bassein, L; Gunella, G; Schiavina, M; Sturani, C, 1983) |
| "The pulmonary hypertension of cor pulmonale can be reversed by sustained correction of hypoxia but continuous oxygen treatment poses problems in clinical practice." | 5.27 | Acute haemodynamic effects of nifedipine at rest and during maximal exercise in patients with chronic cor pulmonale. ( Campbell, IA; Ebejer, MJ; Henderson, AH; Higgins, DA; Singh, H, 1985) |
| "To observe the long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale." | 5.08 | [The long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale]. ( Cheng, X; Li, Q; Yao, Z, 1997) |
| "A two-year-old child dying of pulmonary hypertension and cor pulmonale secondary to bronchopulmonary dysplasia, was demonstrated to have reactive pulmonary hypertension in response to 100% oxygen and isoproterenol infusion." | 5.06 | Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia. ( Bingham, WT; Duncan, WJ; Kasian, GF; Mersal, A; Ninan, A; Sankaran, K; Tyrrell, MJ, 1988) |
| "Non-invasive measurements of right and left ventricular ejection fraction (RVEF, LVEF) by multiple-gated equilibrium radionuclide ventriculography were performed in 19 control subjects, 55 patients with COPD and cor pulmonale, simultaneous right heart catheterizations were performed in 10 patients with cor pulmonale to determine the mean pulmonary artery pressure (mPAP), and then, the acute hemodynamic and functional effects of nifedipine were evaluated." | 3.68 | [Measurement of right and left heart function of COPD and cor pulmonale by radionuclide ventriculography]. ( Wu, WQ, 1992) |
| "The hydraulic load of the right and left ventricles and the clinical effects of nifedipine were evaluated in 8 normal subjects (mean age: 55 years) and 8 patients with cor pulmonale secondary to chronic obstructive lung disease (mean age: 57 years)." | 3.68 | Aortic and pulmonary input impedance in patients with cor pulmonale. ( Chang, MK; Chen, JS; Chen, KS; Chen, YT; Chiang, BN; Hu, WH; Lee, DY; Lee, YS; Lin, JR; Lin, WW, 1990) |
| "The effects of a single dose of nifedipine (20 mg sublingual) on the haemodynamics and parameters of tissue oxygenation were assessed by right heart catheterisation and oximetry of mixed arterial and venous blood in 24 patients with pulmonary hypertension secondary to severe chronic obstructive airways disease." | 3.67 | [Nifedipine in the treatment of chronic cor pulmonale]. ( Arnaud, A; Philip-Joet, F; Saadjian, A; Torresani, J; Tran N'guyen, A, 1986) |
| "The present study was undertaken to evaluate the short-term effects of nitroglycerin, nifedipine, and supplemental oxygen on hemodynamics and gas exchange in 11 patients in stable condition with chronic obstructive pulmonary disease and cor pulmonale." | 3.67 | Pulmonary vasodilator therapy for chronic obstructive pulmonary disease and cor pulmonale. Treatment with nifedipine, nitroglycerin, and oxygen. ( Belli, A; Giudice, JC; Morley, TF; Zappasodi, SJ, 1987) |
| "After 20 mg sublingual nifedipine in 12 men with clinical stable chronic cor pulmonale the mean arterial pressure and systemic vascular resistance fell, cardiac index rose, and mean pulmonary arterial (Ppa) and wedge (Ppaw) pressures, right atrial pressure, and PaO2 remained unchanged." | 3.67 | Nifedipine in chronic cor pulmonale: acute and relatively long-term effects. ( Ashutosh, K; Dunsky, M; Hill, N; Mookherjee, S; Smulyan, H; Vardan, S; Warner, R, 1988) |
| "The effects of a single dose of nifedipine (20 mg sublingually) on hemodynamics and tissue oxygenation were evaluated in 24 patients suffering from pulmonary hypertension secondary to severe chronic obstructive lung disease." | 3.67 | Hemodynamic and oxygen delivery responses to nifedipine in pulmonary hypertension secondary to chronic obstructive lung disease. ( Arnaud, A; Philip-Joet, F; Saadjian, A, 1987) |
| "In the present study the response of the pulmonary circulation to a vasodilator agent (nifedipine) and to low-flow oxygen (FiO2 35%) has been studied both at rest and during exercise (steady state, 25 W) in nine patients with severe scoliosis (spinal curve + 100 degrees, FVC 38%)." | 3.67 | Effects of nifedipine and oxygen on pulmonary haemodynamics in severe scoliosis. ( Corbascio, M; Cornia, BM; Papiris, S; Sturani, C, 1987) |
| "Nifedipine has recently been reported to reduce pulmonary artery pressure and pulmonary vascular resistance during rest and exercise in adult patients with hypoxic pulmonary hypertension from chronic obstructive pulmonary disease." | 1.27 | Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale. ( Fitzpatrick, S; Kennedy, TP; Michael, JR; Rosenstein, BJ, 1984) |
| " The benefit of long-term administration of nifedipine is difficult to predict on the basis of short-term effects." | 1.27 | Oral nifedipine in chronic cor pulmonale secondary to severe chronic obstructive pulmonary disease (COPD). ( Bassein, L; Gunella, G; Schiavina, M; Sturani, C, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (76.67) | 18.7374 |
| 1990's | 7 (23.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rees, J | 1 |
| Michael, JR | 1 |
| Kennedy, TP | 1 |
| Fitzpatrick, S | 1 |
| Rosenstein, BJ | 1 |
| Sturani, C | 2 |
| Bassein, L | 1 |
| Schiavina, M | 1 |
| Gunella, G | 1 |
| Wu, WQ | 2 |
| Rong, ZS | 1 |
| Yang, XQ | 1 |
| Cheng, X | 1 |
| Yao, Z | 1 |
| Li, Q | 1 |
| Vorob'ev, LP | 1 |
| Maev, IV | 1 |
| Butorov, IV | 4 |
| Matkovskiĭ, SK | 3 |
| Butorova, VG | 3 |
| Chen, YT | 1 |
| Chen, KS | 1 |
| Chen, JS | 1 |
| Lin, WW | 1 |
| Hu, WH | 1 |
| Chang, MK | 1 |
| Lee, DY | 1 |
| Lee, YS | 1 |
| Lin, JR | 1 |
| Chiang, BN | 1 |
| Kalra, L | 2 |
| Bone, MF | 2 |
| Sawada, M | 2 |
| Rubin, LJ | 1 |
| Moser, K | 1 |
| Saadjian, A | 2 |
| Philip-Joet, F | 2 |
| Tran N'guyen, A | 1 |
| Arnaud, A | 2 |
| Torresani, J | 1 |
| Morley, TF | 1 |
| Zappasodi, SJ | 1 |
| Belli, A | 1 |
| Giudice, JC | 1 |
| Sil'vestrov, VP | 1 |
| Surovov, IuA | 1 |
| Semin, SN | 1 |
| Pakulin, IA | 1 |
| Larin, NV | 1 |
| Mookherjee, S | 1 |
| Ashutosh, K | 1 |
| Dunsky, M | 1 |
| Hill, N | 1 |
| Vardan, S | 1 |
| Smulyan, H | 1 |
| Warner, R | 1 |
| Bodrug, NI | 2 |
| Sandigurskiĭ, MI | 1 |
| Hussein, A | 1 |
| Koch, I | 1 |
| Schmidt-Redemann, B | 1 |
| Ariaraj, SJ | 1 |
| Kasian, GF | 1 |
| Ninan, A | 1 |
| Duncan, WJ | 1 |
| Bingham, WT | 1 |
| Mersal, A | 1 |
| Tyrrell, MJ | 1 |
| Sankaran, K | 1 |
| Sakaguchi, K | 2 |
| Yamashita, H | 1 |
| Araki, Y | 2 |
| Obata, Y | 2 |
| Sawasa, M | 1 |
| Wasir, HS | 1 |
| Hariharan, V | 1 |
| Malhotra, A | 1 |
| Gopinath, P | 1 |
| Cornia, BM | 1 |
| Corbascio, M | 1 |
| Papiris, S | 1 |
| Santos Bouza, AA | 1 |
| López Pérez, JM | 1 |
| Geggel, RL | 1 |
| Dozor, AJ | 1 |
| Fyler, DC | 1 |
| Reid, LM | 1 |
| Singh, H | 1 |
| Ebejer, MJ | 1 |
| Higgins, DA | 1 |
| Henderson, AH | 1 |
| Campbell, IA | 1 |
4 trials available for nifedipine and Cor Pulmonale
| Article | Year |
|---|---|
[The long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale].
Topics: Adult; Aged; Aged, 80 and over; Calcium Channel Blockers; Delayed-Action Preparations; Double-Blind | 1997 |
[Effects of corinfar, nitrosorbide and apressin on external respiration and blood flow in chronic obstructive bronchitis].
Topics: Blood Circulation; Bronchitis; Humans; Hydralazine; Hypertension, Pulmonary; Isosorbide Dinitrate; N | 1992 |
[Use of a new calcium antagonist nifangin in chronic cor pulmonale].
Topics: Calcium Channel Blockers; Hemodynamics; Humans; Nifedipine; Pulmonary Heart Disease; Respiration | 1991 |
Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
Topics: Albuterol; Bronchopulmonary Dysplasia; Child, Preschool; Diltiazem; Humans; Hydralazine; Hypertensio | 1988 |
26 other studies available for nifedipine and Cor Pulmonale
| Article | Year |
|---|---|
Treatment of pulmonary hypertension in chronic bronchitis and emphysema.
Topics: Adrenergic beta-Agonists; Almitrine; Bronchitis; Humans; Hypertension, Pulmonary; Nifedipine; Pipera | 1984 |
Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale.
Topics: Adult; Combined Modality Therapy; Cystic Fibrosis; Hemodynamics; Humans; Hypoxia; Lung; Male; Nifedi | 1984 |
Oral nifedipine in chronic cor pulmonale secondary to severe chronic obstructive pulmonary disease (COPD).
Topics: Administration, Oral; Aged; Hemodynamics; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Nif | 1983 |
[Hemodynamic studies of pulmonary heart diseases and the effects of nifedipine].
Topics: Aged; Blood Gas Analysis; Catheterization, Swan-Ganz; Echocardiography; Female; Hemodynamics; Humans | 1994 |
[Measurement of right and left heart function of COPD and cor pulmonale by radionuclide ventriculography].
Topics: Blood Pressure; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Nifedipine; Pulmonary | 1992 |
[Nifangin in the combined treatment of chronic cor pulmonale].
Topics: Adult; Calcium Channel Blockers; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Hemody | 1990 |
Aortic and pulmonary input impedance in patients with cor pulmonale.
Topics: Aorta; Blood Pressure; Humans; Lung Diseases, Obstructive; Middle Aged; Nifedipine; Pulmonary Artery | 1990 |
Nifedipine and impaired oxygenation in patients with chronic bronchitis and cor pulmonale.
Topics: Administration, Sublingual; Aged; Bronchitis; Chronic Disease; Female; Humans; Male; Middle Aged; Ni | 1989 |
Oxygen therapy and vasodilator therapy in patients with chronic lung disease: the effects of episodic pulmonary hypertension during sleep and exercise performance.
Topics: Blood Pressure; Chronic Disease; Exercise Test; Hemodynamics; Humans; Hypertension, Pulmonary; Isoso | 1989 |
Long-term effects of nitrendipine on hemodynamics and oxygen transport in patients with cor pulmonale.
Topics: Aged; Biological Transport; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Nitrendipin | 1986 |
[Nifedipine in the treatment of chronic cor pulmonale].
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lactates; Lung Diseases, Obstruc | 1986 |
Pulmonary vasodilator therapy for chronic obstructive pulmonary disease and cor pulmonale. Treatment with nifedipine, nitroglycerin, and oxygen.
Topics: Administration, Oral; Carbon Dioxide; Drug Evaluation; Female; Hemodynamics; Humans; Injections, Int | 1987 |
[Corrective effect of nitrates and calcium antagonists on hemodynamics and ventilation in chronic bronchitis patients with a syndrome of pulmonary hypertension].
Topics: Bronchitis; Calcium Channel Blockers; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension, | 1987 |
Nifedipine in chronic cor pulmonale: acute and relatively long-term effects.
Topics: Administration, Sublingual; Aged; Analysis of Variance; Carbon Dioxide; Chronic Disease; Drug Evalua | 1988 |
[Use of calcium antagonists under outpatient polyclinic conditions in patients with chronic obstructive bronchitis complicated by cor pulmonale].
Topics: Adult; Ambulatory Care; Bronchitis; Carbon Dioxide; Chronic Disease; Drug Evaluation; Hemodynamics; | 1988 |
[Noninvasive methods for assessing the effect of nifedipine on cardiorespiratory function in a patient with cystic fibrosis].
Topics: Adult; Cystic Fibrosis; Humans; Hypertension, Pulmonary; Male; Nifedipine; Pulmonary Heart Disease; | 1988 |
[Treatment of pulmonary heart failure with calcium antagonists].
Topics: Adult; Bronchitis; Chronic Disease; Drug Evaluation; Humans; Male; Middle Aged; Nifedipine; Pulmonar | 1988 |
Nifedipine-aminophylline interaction.
Topics: Aged; Aminophylline; Drug Interactions; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Nifed | 1988 |
[Vasodilator therapy of chronic cor pulmonale].
Topics: Adult; Blood Pressure; Captopril; Cardiac Output; Female; Humans; Isosorbide Dinitrate; Male; Middle | 1986 |
Acute effect of sublingual nifedipine on right and left ventricular function in patients with chronic cor pulmonale.
Topics: Administration, Oral; Aged; Cardiac Output; Female; Humans; Male; Middle Aged; Myocardial Contractio | 1986 |
Hemodynamic and oxygen delivery responses to nifedipine in pulmonary hypertension secondary to chronic obstructive lung disease.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male | 1987 |
[Effects of nifedipine on pulmonary circulation in patients with chronic cor pulmonale].
Topics: Adolescent; Adult; Aged; Cardiac Output; Chronic Disease; Female; Humans; Hypertension, Pulmonary; M | 1987 |
Effects of nifedipine and oxygen on pulmonary haemodynamics in severe scoliosis.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Nifedipine; Oxygen; Physical Exertion; | 1987 |
[Immediate effects of nifedipine and oxygen in acute episodes of chronic cor pulmonale].
Topics: Adult; Aged; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Middle Aged; Nifedipine; O | 1985 |
Effect of vasodilators at rest and during exercise in young adults with cystic fibrosis and chronic cor pulmonale.
Topics: Adult; Chronic Disease; Cystic Fibrosis; Exercise Test; Female; Hemodynamics; Humans; Hydralazine; M | 1985 |
Acute haemodynamic effects of nifedipine at rest and during maximal exercise in patients with chronic cor pulmonale.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Male; Middle Aged; Nifedipi | 1985 |